
Currently out of the existing stock ratings of Gregory Fraser, 60 are a BUY (88.24%), 8 are a HOLD (11.76%).
Analyst Gregory Fraser, has had 56.05% of price targets met with an average potential upside of 39.57%, reached in 235 days on average. Previously, Gregory Fraser worked at TRUIST.
Gregory Fraser has documented 136 price targets and ratings displayed on 19 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on BTMD, biote Corp at 16-Apr-2026.
Analyst best performing recommendations are on EOLS (EVOLUS).
The best stock recommendation documented was for EOLS (EVOLUS) on 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%), with a performance score of 23.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2021
$3
4 years 2 months 24 days ago
(23-Aug-2022)
0/2 (0%)
$2.55 (566.67%)
Hold Since 22-Aug-2022
$13
4 years 2 months 25 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy Since 14-Oct-2021
$10
4 years 5 months 30 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy Since 20-Sep-2021
$12
5 years 1 months 27 days ago
(20-Sep-2021)
0/1 (0%)
$3.86 (47.42%)
Buy Since 20-Sep-2021
$20
5 years 1 months 27 days ago
(20-Sep-2021)
0/1 (0%)
$11.86 (145.70%)